8.4 C
Glasgow
Tuesday, January 20, 2026
spot_img

More News

New way to disarm antibiotic-resistant bacteria and restore healing in chronic wounds

Jim Cornall -
An international team of scientists, led by Nanyang Technological University, Singapore (NTU Singapore), has discovered a new way that...

Fast Track designation for geographic atrophy secondary to AMD treatment

Jim Cornall -
Complement Therapeutics GmbH (CTx) has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation...

Base to Base biotech podcast 42: Treating blood cancers, Scottish Brain Sciences and One BioHub Aberdeen, and is speech...

Jim Cornall -
This week, three interviews, and five guests. We have conversations with Ulrik Tirsted Zeuthen, CEO, and Katarina Cantell, founder...

‘Strong’ phase 2 colorectal cancer results

Jim Cornall -
KAHR Bio has announced topline results from its phase 2a dose-expansion cohort in late-line metastatic microsatellite stable colorectal cancer...

Domain Therapeutics rebrands as Kainova Therapeutics

Jim Cornall -
Kainova Therapeutics is the new name of Domain Therapeutics. The company said its new name and brand reflect its “clinical...

Mercury Bio launches MB-TIP

Jim Cornall -
Mercury Bio Inc. has launched MB-TIP (Mercury Bio - targeting intracellular pathologies) which harnesses proprietary exosome-based yEV technology to...

Beginnings of breast cancer revealed

Jim Cornall -
A study led by PhD student Sara Oster Flayshman under the guidance of Rami Aqeilan and Yotam Drier from...

Reversal of metabolic dysfunction and liver fibrosis shown

Jim Cornall -
Espervita Therapeutics has announced the publication in Cell Metabolism of what it calls 'groundbreaking preclinical data' demonstrating that its...

Neuraxpharm enhances ADHD treatment options in Europe

Jim Cornall -
Neuraxpharm Group has announced the launches in Europe of Tuzulby (methylphenidate hydrochloride) prolonged-release chewable tablets and Paxneury (guanfacine) prolonged-release...

Trenchant BioSystems shows reduction of CGT manufacturing times to 2.5 days

Jim Cornall -
Trenchant BioSystems Inc., a CGT manufacturing platform developer for gene-modified cells, has announced multiple internal and independent external data...

DISCO Pharmaceuticals enters licence agreement with Amgen on cancer

Jim Cornall -
DISCO Pharmaceuticals has announced an exclusive license agreement with Amgen to advance novel therapeutic candidates addressing a target that...

Researchers uncover axonal protein synthesis defect in ALS

Jim Cornall -
Researchers at VIB and KU Leuven in Belgium have identified a molecular process that allows motor neurons to maintain...

Circio and University of Texas Medical Branch to evaluate circVec for treating infectious diseases

Jim Cornall -
Circio Holding ASA, a biotechnology company developing novel circular RNA expression technology for gene and cell therapy, and The...

Aragen launches platform for DNA to IND-enabling clinical supply

Jim Cornall -
Aragen has launched CHOMax, a new cell line development and early manufacturing platform that supports an integrated path from...

Base to Base biotech podcast 41: Eyes, mitochondria and a growing hub

Jim Cornall -
This week, on the first podcast of 2026, we’re talking about eye treatments with Oculis CEO, Riad Sherif, we...

Discovery could lead to new treatments for drug-resistant fungal infections

Jim Cornall -
Fungal infections kill millions of people each year, and modern medicine is struggling to keep up. But researchers at...

LoQus23 Therapeutics nominates first-in-class oral drug candidate for Huntington’s disease

Jim Cornall -
LoQus23 Therapeutics Ltd. has nominated, and is progressing, LQT-23, a drug candidate with the potential to slow or stop...

Earendil Labs to collaborate with Sanofi on bispecific antibodies for autoimmune diseases

Jim Cornall -
Earendil Labs has announced a strategic collaboration with Sanofi to apply Earendil's discovery platform to multiple autoimmune and inflammatory...

Insilico Medicine announces $888m collaboration with Servier

Jim Cornall -
Insilico Medicine, an artificial intelligence (AI)-driven drug discovery company, has announced a multi-year R&D collaboration with Servier, an independent...

Small chip predicts drug side effects and acute kidney injury

Jim Cornall -
Rhabdomyolysis is a condition in which muscle damage—often caused by drug intake—can lead to impaired kidney function and acute...

Awakening dormant immune cells inside tumours to attack cancer​

Jim Cornall -
Within tumours in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media